| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 10/06/2004 | CN1169531C Process for producing freezed dried centipede |
| 10/06/2004 | CN1169527C Methods of modulating serine-threnoine protein kinase function with 5-azaquinoxaline-based compounds |
| 10/06/2004 | CN1169526C Use of substituted morphinan and its pharmaceutically acceptable salt in preparation of medicine for treating sustaining plant state |
| 10/06/2004 | CN1169524C Use of isotretinoin receptor antagonists for inhibition of mucin secretion and use of medicine for curing related diseases |
| 10/05/2004 | US6800778 Process for producing optically active naphthalene derivative and optical resolver therefor |
| 10/05/2004 | US6800761 Form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 10/05/2004 | US6800760 Inhibitors of vascular endothelial growth factor receptor tyrosine kinase |
| 10/05/2004 | US6800740 Variants of native growth hormones having non naturally occurring amino acid sequences or covalent modifications |
| 10/05/2004 | US6800737 Amino acid sequences; anticaner agents, monitoring, diagnosis |
| 10/05/2004 | US6800732 Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same |
| 10/05/2004 | US6800660 Bis(thio-hydrazide amide) compounds; anticancer agents |
| 10/05/2004 | US6800654 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 10/05/2004 | US6800650 For therapy and prophylaxis of diabetes, particularly non-insulin dependent diabetes mellitus and impaired glucose tolerance. |
| 10/05/2004 | US6800645 Substituted azabicyclic compounds |
| 10/05/2004 | US6800644 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 10/05/2004 | US6800638 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 10/05/2004 | US6800632 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 10/05/2004 | US6800627 Central nervous system, cardiovascular and gastrointestinal disorders, diabetes inspidus, sleep apnea |
| 10/05/2004 | US6800625 For therapy of sexual dysfunction |
| 10/05/2004 | US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells |
| 10/05/2004 | US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 10/05/2004 | US6800609 Isolated peptide of the horny layer and user thereof |
| 10/05/2004 | US6800605 With a hypolipidemic agent, an antidiabetic agent, an antidepressant, a bone resorption inhibitor, an appetite suppressant and/or an anti-obesity agent |
| 10/05/2004 | US6800470 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 10/05/2004 | US6800434 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 10/05/2004 | US6800290 Variants can be used in specific immunotherapy of allergic pathologies caused by dust mites |
| 10/05/2004 | CA2338480C Oral liquid mucoadhesive compositions |
| 10/05/2004 | CA2282834C Novel hexanoic acid derivatives |
| 10/05/2004 | CA2249456C Agent for increasing the production of/in breeding and production mammals |
| 10/05/2004 | CA2128956C Tricyclic diazepine vasopressin antagonists |
| 09/30/2004 | WO2004083392A2 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 09/30/2004 | WO2004083257A1 Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 09/30/2004 | WO2004083239A1 Determining drug resistance |
| 09/30/2004 | WO2004083211A1 Pyrazolopyrimidine compound and use thereof |
| 09/30/2004 | WO2004083188A1 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 09/30/2004 | WO2004083186A1 Therapeutic agent for viral hepatitis and carcinostatic agent |
| 09/30/2004 | WO2004083184A1 Receptor antagonist |
| 09/30/2004 | WO2004082704A1 Method of treating inflammtory disease associated with bone destruction |
| 09/30/2004 | WO2004082703A1 Combined use of g-csf with angiogenetic factor |
| 09/30/2004 | WO2004047725A3 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 09/30/2004 | WO2003102014A3 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b |
| 09/30/2004 | WO2003097806A3 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/30/2004 | WO2003092583A3 Methods and compositions for treating ectoparasite infestation |
| 09/30/2004 | WO2003088903A3 Compounds, compositions, and methods |
| 09/30/2004 | WO2003087333A8 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 09/30/2004 | WO2003073097A3 Methods for isolating ligands e.g. t cell epitopes |
| 09/30/2004 | WO2003072740A3 Novel type-1 cytokine receptor glm-r |
| 09/30/2004 | WO2003049703A3 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 09/30/2004 | WO2003039491A3 Novel isoforms of vascular endothelial cell growth inhibitor |
| 09/30/2004 | WO2003014075A3 Novel gamma secretase inhibitors |
| 09/30/2004 | US20040192961 such as 2-nitrophenol by reacting 3-hydroxy-4-methoxybenzophenone with alkyl nitrate in presence of regioselective acid catalyst (sulfuric acid) |
| 09/30/2004 | US20040192914 Compounds and methods |
| 09/30/2004 | US20040192898 Anti-abeta antibodies |
| 09/30/2004 | US20040192886 for use in the treatment and prevention of nervous system, epileptic, pain and vision defects; neuromuscular blocking agents; local anesthetic ; analgesics; neuroprotective agents |
| 09/30/2004 | US20040192785 Inhibition of TNF-alpha-initiated neutrophil response |
| 09/30/2004 | US20040192784 Synergistic mixture; containing hydroxy-3-methylglutaryl/3-/ coenzyme a inhibitor |
| 09/30/2004 | US20040192763 Central nervous system disorders; antidepressants; neurodegenative diseases; restless leg syndrome; antiepileptic agents; headaches; hearing disorders |
| 09/30/2004 | US20040192746 Anticancer agents; central nervous system disorders; sexual disorders; antidiabetic agents; obesity; muscular disorders; alopecia; sepsis; autoimmune disease |
| 09/30/2004 | US20040192745 Method of treating amytrophic lateral sclerosis using melatonin |
| 09/30/2004 | US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide |
| 09/30/2004 | US20040192736 New indoline compounds |
| 09/30/2004 | US20040192733 Hydroxamic acid derivatives |
| 09/30/2004 | US20040192726 Farnesyl protein transferase inhibitors for treating breast cancer |
| 09/30/2004 | US20040192722 Selective iGluR5 receptor antagonists |
| 09/30/2004 | US20040192720 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 09/30/2004 | US20040192711 Kinase inhibitor; therapy for leukemia, lymphoma; skin cancer; autoimmune diseases; antiinflammatory agents; sunscreen agents |
| 09/30/2004 | US20040192702 Heteroaryl alkyl piperazine derivatives |
| 09/30/2004 | US20040192701 Phenlypyridine carbonyl piperazine derivative |
| 09/30/2004 | US20040192694 Use of COX-2 inhibitors as gastroprokinetics |
| 09/30/2004 | US20040192687 Dna-pk inhibitors |
| 09/30/2004 | US20040192685 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 09/30/2004 | US20040192683 Active ingredient combination for treating a dependence on addictive substances or narcotics using medicaments |
| 09/30/2004 | US20040192673 Obesity, non-insulin-dependent diabetes,strokes, sleep disorders; antiischemic and antiemetic agents |
| 09/30/2004 | US20040192670 For inhibiting bone resorption, treating/preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, aniogenesis, atherosclerosis, arthritis, tumor growth and metastasis |
| 09/30/2004 | US20040192667 Novel pyrazole analogs acting on cannabinoid receptors |
| 09/30/2004 | US20040192665 Mesoporphyrin IX covalently linked to doxorubicin; anticarcinogenic, antiproliferative, and antitumor agents; side effect reduction |
| 09/30/2004 | US20040192661 Micronized eplerenone compositions |
| 09/30/2004 | US20040192659 Sodium channel blocker binds SS1 or SS2 site of extracellular region; cyclooxygenase inhibitor; side effect reduction; tetrodotoxin or derivative |
| 09/30/2004 | US20040192628 gene expression inhibition of the kinase to prevent neovascularization, treat cancer |
| 09/30/2004 | US20040192608 Treatment of obesity |
| 09/30/2004 | US20040192607 Transcriptional regulation of the human beta3-adrenergic receptor gene |
| 09/30/2004 | US20040192589 Production of high molecular mass lectins |
| 09/30/2004 | US20040192553 Inosine L-Arginine salt and uses thereof |
| 09/30/2004 | US20040191926 Ptp1b inhibitors and ligands |
| 09/30/2004 | US20040191898 Trangenic diploid cell comprising mutation in kinase allele for use in screening modulator for treatment of anxiety, addiction, withdrawal syndrome, skeletal muscle spasms, convulsive seizures and epilepsy |
| 09/30/2004 | US20040191866 Attenuated microorganisms for the treatment of infection |
| 09/30/2004 | US20040191832 Avidin derivatives and uses thereof |
| 09/30/2004 | US20040191829 Comprises peptide associated with sugar transport protein for identifying modulators for treatment and prevention of cell proliferative disorder |
| 09/30/2004 | US20040191800 Comprises nucleotide sequences coding protein which controls thermogenesis in human skeletal muscle and heart for prevention and treatment of obesity, cachexia, cardiovascular and muscular disorders |
| 09/30/2004 | US20040191785 Methods for diagnosing individuals with an increased risk to develop a deficiency based on mdr1 gene polymorphism |
| 09/30/2004 | US20040191773 Oligoribonucleotides and ribonucleases for cleaving RNA |
| 09/30/2004 | US20040191767 Comprises nucleotide sequences coding hepatitis core protein fusion for generating vaccine to prevent infcetion and treat liver dysfunction; gene therapy and cell-mediated immune response |
| 09/30/2004 | US20040191247 Use of il-18 inhibitors for treating or preventing cns injuries |
| 09/30/2004 | US20040191238 Administering to patient an agent which triggers anion efflux in respiratory tissues via activation of a secretin receptor |
| 09/30/2004 | US20040191236 Administering antigen associated with disease, a dendritic cell binding agent specific for the antigen, and an autologous dendritic cell; immunotherapy |
| 09/30/2004 | US20040191231 Medicinal product for the promotion of wound healing |
| 09/30/2004 | US20040191218 Pharmaceutical compositions and methods for treating cancer |
| 09/30/2004 | US20040191211 Tissue-specific transporter inhibitor |
| 09/30/2004 | US20040191210 Compounds |
| 09/30/2004 | US20040191203 Cosmetic or dermatological composition comprising n-acylaminoamide derivatives |